APVO (Aptevo) Operatsion marja

Aptevo Therapeutics, Inc. (APVO) kompaniyasining korporativ logotipi

Aptevo Therapeutics (APVO) kompaniyasining salohiyati ADAPTIR innovatsiyalariga asoslangan, garchi mablag'lar yetishmasligi haqiqiy foydani kamaytirsa-da. GURU.Markets saytida aks etgan biznesning operatsion samaradorligi tebranishlarni namoyish etadi, bunda 0.00 qiymati joriy rentabellik darajasini tavsiflaydi. Aptevo Therapeutics (APVO) bispesifik antitanachalar orqali immunofarmatsevtika sohasiga kengayishga intilmoqda, biroq geosiyosiy taranglik va sanksiyalar xalqaro klinik sinovlar hamda biomateriallar logistikasiga jiddiy to'sqinlik qilmoqda.

APVO - Aptevo Operatsion rentabellik 04.07.2022 - 20.11.2026 oraligʻida

Aptevo Therapeutics - tahliliy kesimlar va asosiy koʻrsatkichlar (APVO)

Fundamental baholash:Aptevo Therapeutics, Inc., APVO
Aptevo brendining mahsuloti

Aptevo Therapeutics (APVO) kompaniyasining zaif moliyaviy nazorati va muntazam ravishda aksiyalar chiqarishi, uning biotexnologik ishlanmalari shaffofligiga qaramay, kapital barqarorligi uchun xavflarni yuzaga keltirmoqda. Asosiy faoliyatdan olingan foyda ulushining tahlili soliqlardan va foizlardan oldingi operatsion sikl samaradorligini baholash imkonini beradi, bunda salbiy dinamika tashqi moliyalashtirishga bog'liqlikning ortishi va likvidlik yetishmovchiligi xavfidan dalolat beradi.

Aptevo Therapeutics raqobatchilari tahlili

ARGX (argenx N.V.) - Operatsion marja|Sotuvning operatsion rentabelligi BioNTech Pharma BNTX|Sotuvning operatsion marjasi ABVX (ABIVAX)|Operatsion marja ADMA Biologics, Inc. (ADMA)|Operatsion marja PTGX (protagonist-inc.com)|IMVT: Operatsion foyda bo'yicha sotuv rentabelligi|KNSA - Operatsion rentabellik|GRFS: Operatsion rentabellik|ADPT (Adaptive Biotechnologies) - Sotuvning operatsion marjasi|Operatsion foyda bo'yicha sotuv rentabelligi CLDX|Sotuvning operatsion marjasi AUPH|BCRX (BioCryst Pharmaceuticals) - Operatsion foyda koeffitsiyenti|Operatsion rentabellik Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operatsion foyda normasi|Pharvaris N.V. - Sotuvning operatsion marjasi|Operatsion foyda normasi ABCL|TRML: Sotuvning operatsion marjasi|PGEN (Precigen) - Operatsion foyda bo'yicha sotuv rentabelligi|pharming.com (PHAR) - Operatsion rentabellik|Nektar Corp (NKTR) - Operatsion marja|UPB (upstreambio.com) - Operatsion marja|ZBIO: Operatsion foyda normasi|Operatsion marja IMNM|Operatsion faoliyat rentabelligi Gossamer Bio Inc|Operatsion marja KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Operatsion foyda marjasi|PVLA: Sotuvning operatsion marjasi|Operatsion foyda marjasi SVRA|RIGL: Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ANAB|ATXS (Astria Corp) - Operatsion marja|Operatsion foyda bo'yicha sotuv rentabelligi ENGN (enGene Bio)|Operatsion marja RAPT|Operatsion faoliyat rentabelligi Aerovate Therapeutics|Operatsion rentabellik Aclaris Therapeutics Inc. ACRS|Operatsion faoliyat rentabelligi Kyverna Therapeutics Inc. (KYTX)|TLSA - Operatsion rentabellik|CABA: Operatsion rentabellik|VTYX (Ventyx Biosciences, Inc.) - Sotuvning operatsion marjasi|THTX - Operatsion faoliyat rentabelligi|AVTX (avalotx.com) - Operatsion marja|Sotuvning operatsion rentabelligi Eledon Pharmaceuticals Inc. ELDN|Operatsion marja AGEN|CLYM (Climb Bio, Inc.) - Operatsion foyda normasi|Operatsion rentabellik zurabio.com ZURA|ATYR - Sotuvning operatsion marjasi|Adagene Inc - Operatsion marja|ImageneBio (IMA) - Sotuvning operatsion marjasi|Shattuck Therapeutics (STTK) - Operatsion rentabellik|Sotuvning operatsion rentabelligi Equillium Inc (EQ)|Sotuvning operatsion marjasi CNTB|Operatsion foyda bo'yicha sotuv rentabelligi IMUX (Immunic, Inc.)|Operatsion rentabellik Atara Biotherapeutics, Inc. (ATRA)|IFRX - Sotuvning operatsion rentabelligi|Operatsion faoliyat rentabelligi XFOR|Operatsion faoliyat rentabelligi Adicet (ACET)|CELU - Operatsion rentabellik|INMB (INmune Bio, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|BRNS: Operatsion marja|Kezar Life Sciences Inc. (KZR) - Operatsion marja|Operatsion rentabellik SAB Biotherapeutics Inc|Operatsion marja Akari Therapeutics, Plc|Operatsion rentabellik Enlivex Therapeutics Ltd (ENLV)|QTTB - Sotuvning operatsion rentabelligi|Operatsion marja GOVX (GeoVax Corp)|Edesa Biotech (EDSA) - Sotuvning operatsion rentabelligi|iBio Corporation - Operatsion marja|CARM (carismatx.com) - Operatsion foyda bo'yicha sotuv rentabelligi|XTLB (XTL Bio) - Sotuvning operatsion marjasi|Sotuvning operatsion rentabelligi Bolt Biotherapeutics Inc. (BOLT)|Sotuvning operatsion marjasi HCWB|Operatsion foyda bo'yicha sotuv rentabelligi AIM (AIM ImmunoTech, Inc.)|Operatsion marja ADTX|Operatsion faoliyat rentabelligi GRI Bio Corp|Operatsion marja XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Sotuvning operatsion rentabelligi|Revelation Biosciences Corp - Operatsion marja|INDP (Indaptus Therapeutics, Inc.) - Operatsion foyda bo'yicha sotuv rentabelligi|SCNI: Operatsion marja|CALI - Operatsion faoliyat rentabelligi|AFMD (Affimed N.V.) - Operatsion marja|Operatsion rentabellik ALLK|Sotuvning operatsion marjasi HOOK (HOOKIPA Pharma, Inc.)|IGMS - Sotuvning operatsion rentabelligi|Operatsion rentabellik iTeos ITOS|Ocean Bio - Operatsion rentabellik|TC BioPharm Ltd - Operatsion marja|Sotuvning operatsion rentabelligi thirdharmonicbio.com